Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Clinical trial NCT04127916 · UNKNOWN
Trial details
- NCT number
- NCT04127916
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-30
- Primary completion
- 2020-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.